跳至主要内容
临床试验/NCT02619786
NCT02619786Unknown3 期

Therapy of Ventilator-associated Tracheobronchitis Caused by Gram Negative Bacteria With Nebulized Colistin

Mahidol University0 个研究点目标入组 62 人开始时间: 2015年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
入组人数
62
主要终点
Number of Patients With Cure, Improved, Failure or Death

研究概览

简要总结

The purpose of this study is to determine whether inhaled colistin is effective in the treatment of ventilator associated tracheobronchitis due to gram negative organism susceptible to colistin.

详细描述

Patients diagnosed ventilator-associated tracheobronchitis due to gram negative organism are included to the study.The patients will be received colistin inhalation 75 mg every 12 hours at least 5 days.

The primary objective is to evaluate clinical outcome of inhaled colistin. The secondary objectives are microbiological clearance and toxicity of inhaled colistin.

The sample size was estimated to 62 patients.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of ventilator-associated tracheobronchitis caused by gram negative organism.
  • Expected to survive more than 48 hours after enrollment.
  • Received intravenous colistin not more than 48 hours prior enrollment.

排除标准

  • Pregnancy and Lactation
  • Allergy to colistin
  • Serum creatinine > 4 mg/dl or GFR decreased more than 75% from baseline

研究组 & 干预措施

inhaled colistin

Experimental

Inhaled colistin 75 mg mixed with normal saline up to 4 ml every 12 hours at least 5 days

干预措施: Inhaled colistin (Drug)

结局指标

主要结局

Number of Patients With Cure, Improved, Failure or Death

时间窗: through study completion, an average of 2 weeks

Clinical outcome is classified in 4 categories: Cure Improved Failure Death

次要结局

  • Number of Patients With Eradication, Persistence or Superinfection(through study completion, an average of 2 weeks)
  • Number of Patients With Grade 3 Through Grade 5 Adverse Events That Are Related to Study Drug, Graded According to NCI CTCAE Version 3.0(through study completion, an average of 2 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Adhiratha Boonyasiri

Dr.

Mahidol University

相似试验